BibTex RIS Cite

FETAL HYDANTOIN SYNDROME

Year 2012, Volume: 6 Issue: 2, 106 - 110, 01.08.2012

Abstract

An association between hydantoin taken during pregnancy and congenital abnormalities was defined as “fetal hydantoin syndrome”(FHS). Associated minor congenital abnormalities include digit and nail hypoplasia, developmental delay, typical facial appearance, rib anomalies, abnormal palmar creases, hirsutism, and low hairlines. Serious defects such as cardiovascular malformations, cleft lip or palate, and inguinal hernia may also be associated with this syndrome. In this case report, a 13-month-old girl with fetal hydantoin syndrome whose mother had received phenytoin throughout pregnancy has been presented. Her physical examination revealed global developmental delay, craniofacial dysmorphism, and pes equino varus. The patient did not have the cardiovascular malformations associated with FHS.The aim of this case report is to promote awareness among pediatricians regarding the importance of recognizing FHS in infants with congenital abnormalities

References

  • Nicolai J, Vles JS, Aldenkamp AP.Neurodevelopmental delay in children exposed to antiepileptic drugs in utero: a critical review directed at structural study-bias. J Neurol Sci 2008;271(1-2):1-14.
  • Oguni M, Osawa M. Epilepsy and pregnancy. Epilepsia 2004;8:37- 41.
  • Janz D. On major malformations and minor anomalies in the offs- pring of parents with epilepsy. In: Janz D, Dam M, Richens A, Boosi L, Helge HG, Schmidt D, eds. Epilepsy, pregnancy and the child. New York: Raven Press, 1982:211-22.
  • Oğuz A, Sezgin I, Gökalp A, Gültekin A.The fetal hydantoin syndrome. Mater Med Pol 1991;23(4):308-11.
  • Van Dyke DC, Hodge SE, Heide F, Hill LR. Family studies in fetal hydantoin exposure. J Pediatr 1988;113(2):301-6.
  • No authors listed. Teratogenic risks of antiepileptic drugs. Br Med J (Clin Res Ed) 1981;283(6290):515-6.
  • Tavlı V, Ağın H, Sarıtaş T, Çevik B. Fetal hidantoin sendromu. Tur- kiye Klinikleri J Gynecol Obst 2006;16(4):156-8.
  • Kelly TE, Edwards P, Rein M, Miller JQ, Dreifuss FE. Teratogeni- city of anticonvulsant drugs. II: A prospective study. Am J Med Ge- net 1984;19(3):435-43.
  • Azarbayjani F, Danielsson BR. Pharmacologically induced emb- ryonic dysrhythmia and episodes of hypoxia followed by reoxyge- nation: a common teratogenic mechanism for antiepileptic drugs? Teratology 1998;57(3):117-26.
  • D’Souza SW, Robertson IG, Donnai D, Mawer G. Fetal pheny- toin exposure, hypoplastic nails, and jitteriness. Arch Dis Child 1991;66(3):320-4.
  • Buehler BA, Bick D, Delimont D. Prenatal prediction of risk of the fetal hydantoin syndrome. N Engl J Med 1993;329(22):1660-1.
  • Buehler BA, Rao V, Finnell RH. Biochemical and molecular tera- tology of fetal hydantoin syndrome. Neurol Clin 1994;12(4):741-8.

Fetal Hidantoin Sendromu

Year 2012, Volume: 6 Issue: 2, 106 - 110, 01.08.2012

Abstract

Gebelikte hidantoin kullanımı ve konjenital anomali birlikteliği “ Fetal hidantoin sendromu” olarak tanımlanmıştır. Eşlik eden minör konjenital anomaliler; parmak ve tırnak hipoplazisi, büyüme geriliği, tipik yüz görünümü, kosta anomalileri, anormal palmar çizgiler, hirşutizm ve saç çizgisinde düşüklük olabilir. Kardiyovasküler malformasyonlar, yarık damak veya dudak ve inguinal herni bu sendromla ilişkili olabilir.Bu olgu takdiminde annesi gebeliği süresince hidantoin kullanmış, 13 aylık fetal hidantoin sendromlu bir kız hasta sunulmaktadır. Hastanın fizik muayene bulguları; genel gelişme geriliği, kraniyofasiyal dismorfizm ve pes ekino varusu içermekteydi. Olgunun sendrom ile ilişkili bir bulgu olan kardiyovasküler anomalisi yoktu.Bu olgu sunumu ile, pediatri uzmanlarının konjenital anomalili bebeklerde fetal hidantoin sendromunu akla getirmesi gerektiğini vurgulamayı amaçladık.

References

  • Nicolai J, Vles JS, Aldenkamp AP.Neurodevelopmental delay in children exposed to antiepileptic drugs in utero: a critical review directed at structural study-bias. J Neurol Sci 2008;271(1-2):1-14.
  • Oguni M, Osawa M. Epilepsy and pregnancy. Epilepsia 2004;8:37- 41.
  • Janz D. On major malformations and minor anomalies in the offs- pring of parents with epilepsy. In: Janz D, Dam M, Richens A, Boosi L, Helge HG, Schmidt D, eds. Epilepsy, pregnancy and the child. New York: Raven Press, 1982:211-22.
  • Oğuz A, Sezgin I, Gökalp A, Gültekin A.The fetal hydantoin syndrome. Mater Med Pol 1991;23(4):308-11.
  • Van Dyke DC, Hodge SE, Heide F, Hill LR. Family studies in fetal hydantoin exposure. J Pediatr 1988;113(2):301-6.
  • No authors listed. Teratogenic risks of antiepileptic drugs. Br Med J (Clin Res Ed) 1981;283(6290):515-6.
  • Tavlı V, Ağın H, Sarıtaş T, Çevik B. Fetal hidantoin sendromu. Tur- kiye Klinikleri J Gynecol Obst 2006;16(4):156-8.
  • Kelly TE, Edwards P, Rein M, Miller JQ, Dreifuss FE. Teratogeni- city of anticonvulsant drugs. II: A prospective study. Am J Med Ge- net 1984;19(3):435-43.
  • Azarbayjani F, Danielsson BR. Pharmacologically induced emb- ryonic dysrhythmia and episodes of hypoxia followed by reoxyge- nation: a common teratogenic mechanism for antiepileptic drugs? Teratology 1998;57(3):117-26.
  • D’Souza SW, Robertson IG, Donnai D, Mawer G. Fetal pheny- toin exposure, hypoplastic nails, and jitteriness. Arch Dis Child 1991;66(3):320-4.
  • Buehler BA, Bick D, Delimont D. Prenatal prediction of risk of the fetal hydantoin syndrome. N Engl J Med 1993;329(22):1660-1.
  • Buehler BA, Rao V, Finnell RH. Biochemical and molecular tera- tology of fetal hydantoin syndrome. Neurol Clin 1994;12(4):741-8.
There are 12 citations in total.

Details

Other ID JA27PV65AF
Journal Section Research Article
Authors

Fatih Hilmi Çetin This is me

Ebru Arhan This is me

Ayşegül Neşe Kurt This is me

Şebnem Soysal This is me

Tuğba Hirfanoğlu This is me

Ayşe Serdaroğlu This is me

Publication Date August 1, 2012
Submission Date August 1, 2012
Published in Issue Year 2012 Volume: 6 Issue: 2

Cite

Vancouver Çetin FH, Arhan E, Kurt AN, Soysal Ş, Hirfanoğlu T, Serdaroğlu A. FETAL HYDANTOIN SYNDROME. Türkiye Çocuk Hast Derg. 2012;6(2):106-10.


The publication language of Turkish Journal of Pediatric Disease is English.


Manuscripts submitted to the Turkish Journal of Pediatric Disease will go through a double-blind peer-review process. Each submission will be reviewed by at least two external, independent peer reviewers who are experts in the field, in order to ensure an unbiased evaluation process. The editorial board will invite an external and independent editor to manage the evaluation processes of manuscripts submitted by editors or by the editorial board members of the journal. The Editor in Chief is the final authority in the decision-making process for all submissions. Articles accepted for publication in the Turkish Journal of Pediatrics are put in the order of publication, with at least 10 original articles in each issue, taking into account the acceptance dates. If the articles sent to the reviewers for evaluation are assessed as a senior for publication by the reviewers, the section editor and the editor considering all aspects (originality, high scientific quality and citation potential), it receives publication priority in addition to the articles assigned for the next issue.


The aim of the Turkish Journal of Pediatrics is to publish high-quality original research articles that will contribute to the international literature in the field of general pediatric health and diseases and its sub-branches. It also publishes editorial opinions, letters to the editor, reviews, case reports, book reviews, comments on previously published articles, meeting and conference proceedings, announcements, and biography. In addition to the field of child health and diseases, the journal also includes articles prepared in fields such as surgery, dentistry, public health, nutrition and dietetics, social services, human genetics, basic sciences, psychology, psychiatry, educational sciences, sociology and nursing, provided that they are related to this field. can be published.